|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
List of Ongoing Clinical Trials: Patient Summary
GOG-0146O
Phase II Study of Irofulven in Patients With Recurrent or Persistent
Platinum-Sensitive Ovarian Epithelial
or Primary Peritoneal Cancer
Summary
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Phase II trial to study the effectiveness of irofulven in treating patients who have recurrent or persistent ovarian epithelial cancer or primary peritoneal cancer.
Consent Form for Patients | Fast Fact Sheet